Delivery Order SPE2DB25D3012-SPE2DB26FWVUF
Award Date 11/5/25
Potential Completion Date 11/6/25
Potential Value $41K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $15,447.06 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml syringes. This non-competitive, firm fixed-price delivery order was issued on November 3, 2025, with an ultimate completion date of November 4, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Enbrel is a biologic medication used to treat autoimmune conditions including rheumatoid arthritis, and this...
- The Defense Logistics Agency awarded a $30,729.94 delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml syringes, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. ENBREL is a biologic immunosuppressant medication commonly used to treat rheumatoid arthritis and other autoimmune conditions, indicating this procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,778.84 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml syringes. This non-set-aside, firm fixed price delivery order was awarded on September 4, 2025, with an ultimate completion date of September 5, 2025. Performance will occur at the vendor's location in Conshohocken, Pennsylvania. Enbrel is a biologic immunosuppressant medication commonly used to treat rheumatoid arthritis and other inflammatory...
- The Defense Logistics Agency awarded a $22,930.62 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/mL syringes. The contract, issued on May 30, 2025, with an ultimate completion date of June 2, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal medical procurement needs, particularly for military and...
- The Defense Logistics Agency awarded a $17,257.88 delivery order to AmerisourceBergen Drug Corp on June 9, 2025, for the supply of Enbrel 50 mg/ml syringes. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded a $31,043.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml syringes, with an ultimate completion date of September 5, 2025. This non-set-aside award was made competitively and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion vehicle running through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Enbrel 50 mg/mL syringes, valued at $9,158.68 with a firm fixed price structure. The contract has an ultimate completion date of August 15, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This is a non-set-aside competitive award issued as a child delivery order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $22,897 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml syringes, with performance in Conshohocken, Pennsylvania and an ultimate completion date of June 2, 2025. This is a non-set-aside, competitively awarded contract that reflects AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government's military and veteran healthcare systems. The award represents a child order under...
- The Defense Logistics Agency awarded a delivery order valued at $20,608.70 to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL syringes, with an ultimate completion date of August 12, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical distributor and critical vendor for...
- The Defense Logistics Agency awarded a $6,032.22 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml syringes, with an ultimate completion date of June 20, 2025. This non-set-aside competitive award was issued on June 18, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. ENBREL is a biologic immunosuppressant used to treat rheumatoid arthritis and other inflammatory conditions, making this a specialized...